The evolution and value of bleeding assessment tools

Journal of Thrombosis and Haemostasis

Volumn 10, Issue 11, 2012, Pages 2223-2229

  Rydz, Natalia ^a   James, Paula D ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Bleeding scores; Bruising; Epistaxis; Menorrhagia; Mucocutaneous bleeding; Platelet function disorder; Von Willebrand disease

Indexed keywords

VON WILLEBRAND FACTOR;

BLEEDING; BLEEDING ASSESSMENT TOOL; BRAIN HEMORRHAGE; CLINICAL ASSESSMENT TOOL; EPISTAXIS; GASTROINTESTINAL HEMORRHAGE; GINGIVA BLEEDING; HEMARTHROSIS; HEMATOMA; HEMATURIA; HUMAN; MENORRHAGIA; PICTORIAL BLEEDING ASSESSMENT CHART; POSTOPERATIVE HEMORRHAGE; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; REVIEW; ROCKEFELLER UNIVERSITY BLEEDING HISTORY QUESTIONNAIRE; VALIDATION STUDY; VICENZA BLEEDING QUESTIONNAIRE; VON WILLEBRAND DISEASE;

BLEEDING SCORES; BRUISING; EPISTAXIS; MENORRHAGIA; MUCOCUTANEOUS BLEEDING; PLATELET FUNCTION DISORDER; VON WILLEBRAND DISEASE;

ALGORITHMS; BLOOD COAGULATION DISORDERS; BLOOD PLATELET DISORDERS; FEMALE; HEMORRHAGE; HEMORRHAGIC DISORDERS; HEMOSTASIS; HUMANS; MALE; MENORRHAGIA; PREVALENCE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SYMPTOM ASSESSMENT; VON WILLEBRAND DISEASES;

EID: 84868143302     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2012.04923.x     Document Type: Review

References (37)

1. Sadler JE. von Willebrand disease type 1: a diagnosis in search of a disease. Blood 2003; 101: 2089-93.
2. Mauer AC, Khazanov NA, Levenkova N, Tian S, Barbour EM, Khalida C, Tobin JN, Coller BS. Impact of sex, age, race, ethnicity and aspirin use on bleeding symptoms in healthy adults. J Thromb Haemost 2011; 9: 100-8.
3. Srámek A Sr, Eikenboom JC, Briët E, Vandenbroucke JP, Rosendaal FR. Usefulness of patient interview in bleeding disorders. Arch Intern Med 1995; 155: 1409-15.
4. Sadler JE, Rodeghiero F. Provisional criteria for the diagnosis of VWD type 1. J Thromb Haemost 2005; 3: 775-7.
5. Rodeghiero F, Castaman G, Tosetto A, Batlle J, Baudo F, Cappelletti A, Casana P, De Bosch N, Eikenboom JCJ, Federici AB, Lethagen S, Linari S, Srivastava A. The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study. J Thromb Haemost 2005; 3: 2619-26.
6. Tosetto A, Rodeghiero F, Castaman G, Goodeve A, Federici AB, Batlle J, Meyer D, Fressinaud E, Mazurier C, Goudemand J, Eikenboom J, Schneppenheim R, Budde U, Ingerslev J, Vorlova Z, Habart D, Holmberg L, Lethagen S, Pasi J, Hill F, et al. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost 2006; 4: 766-73.
7. Bowman M, Mundell G, Grabell J, Hopman WM, Rapson D, Lillicrap D, James P. Generation and validation of the Condensed MCMDM-1VWD Bleeding Questionnaire for von Willebrand disease. J Thromb Haemost 2008; 6: 2062-6.
8. Tosetto A, Castaman G, Plug I, Rodeghiero F, Eikenboom J. Prospective evaluation of the clinical utility of quantitative bleeding severity assessment in patients referred for hemostatic evaluation. J Thromb Haemost 2011; 9: 1143-8.
9. Azzam HAG, Goneim HR, El-Saddik AM, Azmy E, Hassan M, El-Sharawy S. The condensed MCMDM-1 VWD bleeding questionnaire as a predictor of bleeding disorders in women with unexplained menorrhagia. Blood Coagul Fibrinolysis 2012; 23: 311-15.
10. Castaman G, Rodeghiero F, Tosetto A, Cappelletti A, Baudo F, Eikenboom JCJ, Federici AB, Lethagen S, Linari S, Lusher J, Nishino M, Petrini P, Srivastava A, Ungerstedt JS. Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter study. J Thromb Haemost 2006; 4: 2164-9.
11. Rodeghiero F, Tosetto A, Abshire T, Arnold DM, Coller B, James P, Neunert C, Lillicrap D. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost 2010; 8: 2063-5.
12. Mauer AC, Barbour EM, Khazanov NA, Levenkova N, Mollah SA, Coller BS. Creating an ontology-based human phenotyping system: the Rockefeller University bleeding history experience. Clin Transl Sci 2009; 2: 382-5.
13. McKay H, Derome F, Haq MA, Whittaker S, Arnold E, Adam F, Heddle NM, Rivard GE, Hayward CPM. Bleeding risks associated with inheritance of the Quebec platelet disorder. Blood 2004; 104: 159-65.
14. Dilley A, Drews C, Miller C, Lally C, Austin H, Ramaswamy D, Lurye D, Evatt B. von Willebrand disease and other inherited bleeding disorders in women with diagnosed menorrhagia. Obstet Gynecol 2001; 97: 630-6.
15. Rees M. Menorrhagia. Br Med J 1987; 294: 759-62.
16. Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 1998; 351: 485-9.
17. Edlund M, Blombäck M, von Schoultz B, Andersson O. On the value of menorrhagia as a predictor for coagulation disorders. Am J Hematol 1996; 53: 234-8.
18. Philipp CS, Dilley A, Miller CH, Evatt B, Baranwal A, Schwartz R, Bachmann G, Saidi P. Platelet functional defects in women with unexplained menorrhagia. J Thromb Haemost 2003; 1: 477-84.
19. Kirtava A, Crudder S, Dilley A, Lally C, Evatt B. Trends in clinical management of women with von Willebrand disease: a survey of 75 women enrolled in haemophilia treatment centres in the United States. Haemophilia 2004; 10: 158-61.
20. Higham JM, O'Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 1990; 97: 734-9.
21. Philipp CS, Faiz A, Dowling NF, Beckman M, Owens S, Ayers C, Bachmann G. Development of a screening tool for identifying women with menorrhagia for hemostatic evaluation. Am J Obstet Gynecol 2008; 198: 163.e1-8.
22. Philipp CS, Faiz A, Heit JA, Kouides PA, Lukes A, Stein SF, Byams V, Miller CH, Kulkarni R. Evaluation of a screening tool for bleeding disorders in a US multisite cohort of women with menorrhagia. Am J Obstet Gynecol 2011; 204: 209.e1-7.
23. Katsanis E, Luke K, Hsu E, Li M, Lillicrap D. Prevalence and significance of mild bleeding disorders in children with recurrent epistaxis. J Pediatr 1988; 113: 73-6.
24. Dean JA, Blanchette VS, Carcao MD, Stain AM, Sparling CR, Siekmann J, Turecek PL, Lillicrap D, Rand ML. von Willebrand disease in a pediatric-based population - comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay. Thromb Haemost 2000; 84: 401-9.
25. Hedlund-Treutiger I, Revel-Vilk S, Blanchette VS, Curtin JA, Lillicrap D, Rand ML. Reliability and reproducibility of classification of children as 'bleeders' vs. 'non-bleeders' using a questionnaire for significant mucocutaneous bleeding. J Pediatr Hematol Oncol 2004; 26: 488-91.
26. Bowman M, Riddel J, Rand ML, Tosetto A, Silva M, James PD. Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding questionnaire. J Thromb Haemost 2009; 7: 1418-21.
27. Biss TT, Blanchette VS, Clark DS, Bowman M, Wakefield CD, Silva M, Lillicrap D, James PD, Rand ML. Quantitation of bleeding symptoms in children with von Willebrand disease: use of a standardized pediatric bleeding questionnaire. J Thromb Haemost 2010; 8: 950-6.
28. Biss TT, Blanchette VS, Clark DS, Wakefield CD, James PD, Rand ML. Use of a quantitative pediatric bleeding questionnaire to assess mucocutaneous bleeding symptoms in children with a platelet function disorder. J Thromb Haemost 2010; 8: 1416-19.
29. Marcus PD, Nire KG, Grooms L, Klima J, O'Brien SH. The power of a standardized bleeding score in diagnosing paediatric type 1 von Willebrand's disease and platelet function defects. Haemophilia 2011; 17: 223-7.
30. Bidlingmaier C, Grote V, Budde U, Olivieri M, Kurnik K. Prospective evaluation of a pediatric bleeding questionnaire and the ISTH bleeding assessment tool in children and parents in clinical routine. J Thromb Haemost 2012; 10: 1335-41.
31. Sidonio RF, Gunawardena S, Shaw PH, Ragni M. Predictors of von Willebrand disease in children. Pediatr Blood Cancer 2012; 58: 736-40.
32. James PD, Bowman M, Grabell J, Dwyre L, Rapson D. Prospective validation of the condensed MCMDM-1 VWD bleeding questionnaire for platelet function disorders. J Thromb Haemost 2011; 9(Suppl. 2): 549.
33. Tosetto A, Rodeghiero F, Castaman G, Goodeve A, Federici AB, Batlle J, Meyer D, Goudemand J, Eikenboom J, Schneppenheim R, Budde U, Ingerslev J, Lethagen S, Hill FG, Peake I. A comparison between two semi-quantitative bleeding scales for the diagnosis and assessment of bleeding severity in type 1 von Willebrand disease. Haemophilia 2011; 17: 165-6.
34. James PD, Biss TT, Clark DS, Grabell J, Riddel J, Silva M, Rapson D, Rand M. -1 to +4 vs. 0 to +3?: comparing scoring systems for bleeding symptoms in the condensed MCMDM-1 VWD and the pediatric bleeding questionnaires. J Thromb Haemost 2011; 9(Suppl. 2): 200.
35. Silwer J. von Willebrand's disease in Sweden. Acta Paediatr Scand Suppl 1973; 238: 1-159.
36. Lak M, Peyvandi F, Mannucci PM. Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand disease. Br J Haematol 2000; 111: 1236-9.
37. Federici AB. Clinical diagnosis of von Willebrand disease. Haemophilia 2004; 10(Suppl. 4): 169-76.